Katalin Dobra

2.5k total citations
71 papers, 1.9k citations indexed

About

Katalin Dobra is a scholar working on Pulmonary and Respiratory Medicine, Cell Biology and Molecular Biology. According to data from OpenAlex, Katalin Dobra has authored 71 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Pulmonary and Respiratory Medicine, 28 papers in Cell Biology and 26 papers in Molecular Biology. Recurrent topics in Katalin Dobra's work include Occupational and environmental lung diseases (37 papers), Proteoglycans and glycosaminoglycans research (25 papers) and Pleural and Pulmonary Diseases (21 papers). Katalin Dobra is often cited by papers focused on Occupational and environmental lung diseases (37 papers), Proteoglycans and glycosaminoglycans research (25 papers) and Pleural and Pulmonary Diseases (21 papers). Katalin Dobra collaborates with scholars based in Sweden, Türkiye and Greece. Katalin Dobra's co-authors include Anders Hjerpe, Tünde Szatmári, Nikos K. Karamanos, Gustav Nilsonne, Mikael Björnstedt, Ilona Kovalszky, Xiaojuan Sun, Annika Dejmek, Spyros S. Skandalis and Anna-Klara Rundlöf and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Katalin Dobra

70 papers receiving 1.9k citations

Peers

Countries citing papers authored by Katalin Dobra

Since Specialization

Citations

This map shows the geographic impact of Katalin Dobra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katalin Dobra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katalin Dobra more than expected).

Fields of papers citing papers by Katalin Dobra

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katalin Dobra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katalin Dobra. The network helps show where Katalin Dobra may publish in the future.

Co-authorship network of co-authors of Katalin Dobra

This figure shows the co-authorship network connecting the top 25 collaborators of Katalin Dobra. A scholar is included among the top collaborators of Katalin Dobra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katalin Dobra. Katalin Dobra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis 2025 ·Cancers ·(unknown), Enes Demir, (unknown), (unknown), (unknown), (unknown), (unknown), Annica K. B. Gad, Katalin Dobra	0
2	Myeloid cells from Langerhans cell histiocytosis patients exhibit increased vesicle trafficking and an altered secretome capable of activating NK cells 2023 ·Haematologica ·Daniel W. Hagey, Egle Kvedaraite, Mira Akber, André Görgens, (unknown), Tatiana von Bahr Greenwood, (unknown), (unknown), (unknown), Henrik Arnell, Katalin Dobra, Nikolas Herold, Mattias Svensson, Samir EL Andaloussi, Jan‐Inge Henter, Magda Lourda	3
3	Comparison of immunohistochemical mesothelial biomarkers in paired biopsies and effusion cytology cell blocks from pleural mesothelioma 2023 ·Cytopathology ·(unknown), (unknown), Tomas Seidal, (unknown), (unknown), (unknown), (unknown), Annika Dejmek, Katalin Dobra, Hans Brunnström	4
4	PD-L1 Expression in Non-Small Cell Lung Cancer Specimens: Association with Clinicopathological Factors and Molecular Alterations 2022 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Kajsa Ericson Lindquist, (unknown), (unknown), Tomas Seidal, Annika Dejmek, Katalin Dobra, Maria Planck, Hans Brunnström	10
5	Real-World Diagnostic Accuracy and Use of Immunohistochemical Markers in Lung Cancer Diagnostics 2021 ·Biomolecules ·Kajsa Ericson Lindquist, (unknown), (unknown), (unknown), (unknown), (unknown), Felix Haglund, (unknown), (unknown), Katalin Dobra, Hans Brunnström	5
6	Higher concordance of PD‐L1 expression between biopsies and effusions in epithelioid than in nonepithelioid pleural mesothelioma 2021 ·Cancer Cytopathology ·(unknown), Tomas Seidal, (unknown), Katalin Dobra, Hans Brunnström, Annika Dejmek	4
7	PD-L1 Testing in Cytological Non-Small Cell Lung Cancer Specimens: A Comparison with Biopsies and Review of the Literature 2021 ·Acta Cytologica ·(unknown), Kajsa Ericson Lindquist, Tomas Seidal, (unknown), (unknown), Lena Tran, (unknown), (unknown), (unknown), Katalin Dobra, Annika Dejmek, Maria Planck, Hans Brunnström	12
8	Mapping the Interactome of the Nuclear Heparan Sulfate Proteoglycan Syndecan-1 in Mesothelioma Cells 2020 ·Biomolecules ·(unknown), Jatin Shrinet, (unknown), Jonas Fuxe, Katalin Dobra, Anders Hjerpe	12
9	Management of cytological material, pre‐analytical procedures and bio‐banking in effusion cytopathology 2018 ·Cytopathology ·(unknown), (unknown), Katalin Dobra, Anders Hjerpe, Ambrogio Fassina, Pınar Fırat	23
10	Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis 2018 ·Liver International ·Erik von Seth, (unknown), Katalin Dobra, Anders Hjerpe, Urban Arnelo, Stephan Haas, Annika Bergquist	14
11	Chemosensitivity and resistance testing in malignant effusions with focus on primary malignant mesothelioma and metastatic adenocarcinoma 2016 ·PubMed ·(unknown), Tünde Szatmári, Anders Hjerpe, Katalin Dobra	2
12	Syndecan-1 alters heparan sulfate composition and signaling pathways in malignant mesothelioma 2015 ·Cellular Signalling ·(unknown), Romain R. Vivès, Amal Seffouh, Nikolaos A. Afratis, Arie Oosterhof, Toin H. Van Kuppevelt, Nikos K. Karamanos, Muzaffer Metintaş, Anders Hjerpe, Katalin Dobra, Tünde Szatmári	20
13	Proteome Screening of Pleural Effusions Identifies Galectin 1 as a Diagnostic Biomarker and Highlights Several Prognostic Biomarkers for Malignant Mesothelioma 2013 ·Molecular & Cellular Proteomics ·(unknown), Henrik J. Johansson, Jenny Forshed, (unknown), Muzaffer Metintaş, Katalin Dobra, Janne Lehtiö, Anders Hjerpe	36
14	Microenvironment-Dependent Phenotypic Changes in a SCID Mouse Model for Malignant Mesothelioma 2013 ·Frontiers in Oncology ·(unknown), Gustav Nilsonne, (unknown), Anders Hjerpe, Katalin Dobra	3
15	Novel Genes and Pathways Modulated by Syndecan-1: Implications for the Proliferation and Cell-Cycle Regulation of Malignant Mesothelioma Cells 2012 ·PLoS ONE ·Tünde Szatmári, (unknown), (unknown), (unknown), (unknown), Andrey Alexeyenko, Anders Hjerpe, Katalin Dobra	36
16	Phenotype-dependent apoptosis signalling in mesothelioma cells after selenite exposure 2009 ·Journal of Experimental & Clinical Cancer Research ·Gustav Nilsonne, Eric Olm, (unknown), (unknown), (unknown), (unknown), Anna-Klara Rundlöf, Aristi P. Fernandes, Mikael Björnstedt, Katalin Dobra	19
17	Effect of syndecan‐1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains 2009 ·Cell Proliferation ·(unknown), Eleni Fthenou, Juan C. Castro, Bálint Péterfia, Ilona Kovalszky, László Szilák, George N. Tzanakakis, Katalin Dobra	25
18	Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions 2009 ·Lung Cancer ·(unknown), (unknown), Katalin Dobra, Anders Hjerpe	37
19	Molecular characterization of tumour heterogeneity and malignant mesothelioma cell differentiation by gene profiling 2005 ·The Journal of Pathology ·Xiaojuan Sun, Lei Wei, Johan Lidén, Hui Gao, Karin Dahlman‐Wright, Anders Hjerpe, Katalin Dobra	28
20	Upregulation of 9 genes, including that for thioredoxin, during epithelial differentiation of mesothelioma cells 2000 ·Differentiation ·Xun Sun, Katalin Dobra, Mikael Björnstedt, Anders Hjerpe	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact